Two people wearing PPE looking across a construction site

Tay Cities BioMedical cluster

Details
X

Get in touch

Summary

Sector
Research
Value
£27m
Location
Dundee
Status
Live
Customer
University of Dundee
Get social and share

Innovation Hub to foster research and collaboration

Robertson is delivering two key projects as part of a BioMedical Cluster – the Tay Cities Regional Innovation Hub and the MedTech R&D Unit. The new Innovation Hub will not only provides training and support for biotechnology students and early-careers professionals but also foster innovation and intercommunication between industry and academic partners. The MedTech R&D unit offers unique capabilities such as cadaveric facilities, state of the art imaging and ISO-certified prototype production to pre-clinical level.

Key facts

These projects have been independently assessed to have an economic impact predicted to be:

281

biomedical jobs created by 2033

800

new jobs by 2053

£190 million

benefit to the local economy by 2053

Tay Cities Innovation Hub

We will create a new 4,790m2 three-storey, two-wing facility that is a collaborative initiative between the University of Dundee, Scottish Enterprise, and other key stakeholders, which will foster innovation and high growth in the biomedical industry. 

The development responds to the increasing demand for biotechnology and pharmaceutical research and development facilities in Scotland. 

This world-class life sciences environment will attract innovative, entrepreneurial expertise, so that high-growth companies can be formed, providing new treatments and technologies, as well as jobs for the region.

The hub includes has a modular design, enabling companies to lease the right amount of laboratory and office space they need to grow. 

MedTech R&D Unit

Robertson is also developing a unique medical technologies innovation environment at Ninewells Hospital and Medical School. In refurbishing, Wilson House in Dundee Medipark (near Ninewells), the new facility will bring together the University, NHS, and industry to enable new technologies to move quickly from prototyping to commercialization to adoption by the NHS, ultimately generating new wealth for the region and improving health outcomes.

Community impact

In delivering these projects, we will take a proactive approach to inclusive growth to unlock opportunities for community participation and engagement, local employment and local supply chains, and participation from under-represented groups in the regional life sciences sector.